Private-equity firm Carlyle Group is in exclusive talks to acquire medical-device maker Baxter’s kidney-care spinoff Vantive for more $4 billion, including debt. The two parties entered exclusive negotiations in late June, according to people familiar with the situation, and a deal could be announced in the coming weeks. It is still possible talks could fall apart or another suitor could prevail. The separation of Vantive from Baxter was expected to take place in the second half of this year. Baxter’s kidney-care company had about $4.5 billion in revenue last year and more than 22,000 employees.
Read the full article: Carlyle in Advanced Talks to Acquire Baxter’s Vantive //
Source: https://www.wsj.com/finance/investing/carlyle-in-advanced-talks-to-acquire-baxters-vantive-2902df8d